Home » GW Pharma’s Cannabis Medicine to Win UK Approval
GW Pharma’s Cannabis Medicine to Win UK Approval
GW Pharmaceuticals Thursday announced its cannabis-based medicine for multiple sclerosis sufferers will win regulatory approval in the UK before the end of next month.
Evening Standard
Evening Standard
Upcoming Events
-
07May
-
14May
-
30May